Nelfinavir

VIRACEPT®

Overview

Nelfinavir is an orally admin­istered drug that belongs to a treatment classification called protease inhibitors. Preclinical data suggests that Nelfinavir may overcome resistance to proteasome inhibitors in multiple myeloma.

SparkCures ID 323
Brand Name Viracept®
Generic Name Nelfinavir
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.